Gender disparities have been a significant issue in various professional fields in Japan and South Korea.1,2 Both countries have a historical background shaped by Confucianism, which has influenced perspectives on gender inequality. The low proportion of female faculty members in universities has been a long-standing issue in both Japan and South Korea. Recent survey results indicated that the proportion of female faculty members decreases as academic rank increases in Japan.3 In order to expand women’s participation and promote diversity in all areas of society, the Japanese government launched the progressive initiative “Empowerment Network” in 2018.4 This initiative aimed to increase the percentage of women in leadership positions to at least 30% by 2020 across all sectors of society, including politics, national and local civil service, the private sector, education, and research. Similar efforts have been undertaken in South Korea.5
A major mission of university pharmacy schools is to train pharmacists. Previous studies show that there were a high proportion of female pharmacists and students in pharmacy departments of universities.6,7 But there haven’t been any studies that have looked into whether there are gender differences among professors in pharmacy schools, whether there are more female professors at universities or laboratories, or whether there are more female professors at female universities.
In this study we investigate the gender differences among professors in pharmacy schools in Japan and Korea. The investigation was conducted based on public information (primarily from university websites). This study included 73 universities in Japan and 35 universities in South Korea as of November 2023 (Supplementary 1). Detailed method is described in Supplementary 2. There were 1965 professors at pharmacy schools were identified in Japan and South Korea. Of these, 1527 were from Japan and 438 were from South Korea (Table 1).
Table 1.
Gender distribution of pharmacy school professors in Japan and South Korea.
| Classification | Japan |
South Korea |
Total |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of professors | Number of male professors | % | Number of female professors | % | Number of professors | Number of male professors | % | Number of female professors | % | Number of professors | Number of male professors | % | Number of female professors | % | |
| Basic specialty | 1185 | 1075 | 90.7% | 110 | 9.3% | 369 | 269 | 72.9% | 100 | 27.1% | 1554 | 1344 | 86.5% | 210 | 13.5% |
| Clinical specialty | 342 | 290 | 84.8% | 52 | 15.2% | 69 | 25 | 36.2% | 44 | 63.8% | 411 | 315 | 76.6% | 96 | 23.4% |
| Basic specialty | |||||||||||||||
| Chemistry, physics, biology | 784 | 717 | 91.5% | 67 | 8.5% | 238 | 185 | 77.7% | 53 | 22.3% | 1022 | 902 | 88.3% | 120 | 11.7% |
| Hygiene | 100 | 85 | 85.0% | 15 | 15.0% | 34 | 20 | 58.8% | 14 | 41.2% | 134 | 105 | 78.4% | 29 | 21.6% |
| Pharmacology | 126 | 114 | 90.5% | 12 | 9.5% | 30 | 19 | 63.3% | 11 | 36.7% | 156 | 133 | 85.3% | 23 | 14.7% |
| Drugs | 175 | 159 | 90.9% | 16 | 9.1% | 67 | 45 | 67.2% | 22 | 32.8% | 242 | 204 | 84.3% | 38 | 15.7% |
| Clinical specialty | |||||||||||||||
| Disease and drug therapy | 192 | 165 | 85.9% | 27 | 14.1% | 29 | 12 | 41.4% | 17 | 58.6% | 221 | 177 | 80.1% | 44 | 19.9% |
| Laws, systems, and ethics | 39 | 30 | 76.9% | 9 | 23.1% | 22 | 6 | 27.3% | 16 | 72.7% | 61 | 36 | 59.0% | 25 | 41.0% |
| Clinical training | 111 | 95 | 85.6% | 16 | 14.4% | 18 | 7 | 38.9% | 11 | 61.1% | 129 | 102 | 79.1% | 27 | 20.9% |
| Founder | |||||||||||||||
| National university | 333 | 313 | 94.0% | 20 | 6.0% | 143 | 99 | 69.2% | 44 | 30.8% | 476 | 412 | 86.6% | 64 | 13.4% |
| Private university | 1194 | 1023 | 85.7% | 171 | 14.3% | 295 | 195 | 66.1% | 100 | 33.9% | 1489 | 1218 | 81.8% | 271 | 18.2% |
| Faculty composition | |||||||||||||||
| University | 1307 | 1144 | 87.5% | 163 | 12.5% | 438 | 294 | 67.1% | 144 | 32.9% | 1745 | 1438 | 82.4% | 307 | 17.6% |
| College | 220 | 192 | 87.3% | 28 | 12.7% | 0 | 0 | 0.0% | 0 | 0.0% | 220 | 192 | 87.3% | 28 | 12.7% |
| Location | |||||||||||||||
| Capital | 640 | 543 | 84.8% | 97 | 15.2% | 237 | 162 | 68.4% | 75 | 31.6% | 877 | 705 | 80.4% | 172 | 19.6% |
| Regional | 887 | 793 | 89.4% | 94 | 10.6% | 201 | 132 | 65.7% | 69 | 34.3% | 1088 | 925 | 85.0% | 163 | 15.0% |
| Gender of students | |||||||||||||||
| Co-ed | 1438 | 1261 | 87.7% | 177 | 12.3% | 387 | 267 | 69.0% | 120 | 31.0% | 1825 | 1528 | 83.7% | 297 | 16.3% |
| Women’s university | 89 | 75 | 84.3% | 14 | 15.7% | 51 | 27 | 52.9% | 24 | 47.1% | 140 | 102 | 72.9% | 38 | 27.1% |
| Total | 1527 | 1336 | 87.5% | 191 | 12.5% | 438 | 294 | 67.1% | 144 | 32.9% | 1965 | 1630 | 83.0% | 335 | 17.0% |
In both countries, the number of female professors was low in pharmacy schools, with the proportion of female professors in Japan was 12.5% (191 of 1527), and 32.9% in South Korea (144 of 438). This pattern consistently existed in all research fields, including basic research (Physics, Chemistry, Biology, Hygiene, Pharmacology, and Pharmaceutical Sciences) and clinical research (Pathology and Drug Therapy, Laws, Systems, and Ethics, and Clinical Training) (Table 1). In South Korea, 63.8% (44 of 69) of professors engaged in clinical research were female. Moreover, over 50% of professors in the fields of pathology and drug therapy, as well as in the areas of law, systems, ethics, and clinical training, were women in South Korea. While female professors constituted less than 50% across all specialties in Japan, with the highest proportion observed in the field of “laws, systems, and ethics,” which included 23.1% (9 of 39) of women. Furthermore, the gender disparities existed in different types of universities by considering founder, faculty composition, location, and gender of students in these two countries (Table 1). For instance, approximately half of the professors were female (47.1%, 24 out of 51) at women’s universities in South Korea, but none of universities including in this study in Japan had female professors exceeding 50%.
According to the 2024 World Economic Forum Gender Gap Index,1 Japan was ranked 118th and South Korea was ranked 100th. The greater gender disparity in Japan than in South Korea on the number of pharmacy school professors are consistent with the gender gap index. Women may require longer periods of leave from work due to marriage and childbirth, which may impede their career progression.2 This could be one of the reasons for the lower number of women in the highest academic positions, such as professors. Previous statistics have shown that there are more female students and practitioners in pharmacy than their male counterparts,6,7 In both Japan and Korea, clinical professors or professors majored in clinical research in pharmacy departments are required to have practical clinical experience, as opposed to continuing to conduct basic research at a university after graduation.8 Many professors may have acquired clinical experience in hospitals or pharmacies prior to returning to academia and many female researchers stay in practical clinical pharmacy and not move to academia as they don’t have role model or leader to inspire them. In conclusion, both Japan and South Korea exhibited gender disparity among professors in university pharmacy departments. It is essential to increase the representation of female professors and to promote female leadership within these departments in both countries.
Contributors
HM, HS, EH contributed to the study conception and design. Material preparation, literature search and data collection were performed by HS and EO. Analyses were performed by HS and MH. Funding acquisition, investigation, project administration, and resources were prepared by HM. All authors reviewed and commented on the drafted manuscript and all authors approved the final manuscript.
Declaration of interests
All authors declare no conflicts of interest.
Acknowledgements
This study was supported by a grant from JSPS KAKENHI (number: JP20K20251) and Japan Health and Labor Sciences Research Grant (number: 21KC2006).
Ethical considerations: This study did not require institutional review board approval or patient informed consent because it was based on publicly available information and included no patient records.
Footnotes
Supplementary data related to this article can be found at https://doi.org/10.1016/j.lanwpc.2025.101469.
Appendix ASupplementary data
References
- 1.World Economic Forum . 2024. Global gender gap 2024, insight report.https://www3.weforum.org/docs/WEF_GGGR_2024.pdf [Google Scholar]
- 2.Yamaguchi K. 2019. A lack of gender equality in career opportunity and long work hours perpetuate wage differences between men and women.https://www.imf.org/en/Publications/fandd/issues/2019/03/gender-equality-in-japan-yamaguchi [Google Scholar]
- 3.Hori R.S. Progress and problems of gender equality in Japanese academics and geosciences. Adv Geosci. 2020;53:195–203. doi: 10.5194/adgeo-53-195-2020. [DOI] [Google Scholar]
- 4.Gender Equalty Bureau Cabinet Office in Japan Expansion of women’s participation in policy and decision-making processes in all fields in society. https://www.gender.go.jp/english_contents/mge/process/index.html
- 5.Ministry of Gender Equality and Family Development and implementation of the “the 2nd framework plan for gender equality policies”. https://www.mogef.go.kr/eng/pc/eng_pc_f001.do
- 6.Devraj R., Warholak T., Planas L.G. Seeking gender equity in pharmacy academia. Am J Pharm Educ. 2023;87(3) doi: 10.5688/ajpe9050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bissell B.D., Johnston J.P., Smith R.R., et al. Gender inequity and sexual harassment in the pharmacy profession: evidence and call to action. Am J Health Syst Pharm. 2021;78(22):2059–2076. doi: 10.1093/ajhp/zxab275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ministry of Health, Labour and Welfare Standards for faculty members (including practitioner faculty members) in the School of Pharmacy. https://www.mext.go.jp/b_menu/shingi/chukyo/chukyo3/023/siryo/attach/1380562.htm
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
